Document

15-12B 1 form15.htm 15-12B Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________________________

FORM 15

_______________________________________

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

001-36289

Commission File Number

_______________________________________

GENOCEA BIOSCIENCES, INC.

(Exact name of registrant as specified in its charter)

_______________________________________

Genocea Biosciences, Inc.

100 Acorn Park Drive, 5th Floor

Cambridge, MA 02140

(617) 876-8191

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

Common Stock, par value $0.001 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

_______________________________________

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:


Rule 12g-4(a)(1)						☒
Rule 12g-4(a)(2)						☐
Rule 12h-3(b)(1)(i)						☒
Rule 12h-3(b)(1)(ii)						☐
Rule 15d-6						☐
Rule 15d-22(b)						☐

Approximate number of holders of record as of the certification or notice date: 15

Pursuant to the requirements of the Securities Exchange Act of 1934, Genocea Biosciences, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date:

June 13, 2022

By:

/s/ Diantha Duvall

Name:

Diantha Duvall

Title:

Chief Financial Officer

SEC Form 15-12B filed by Genocea Biosciences Inc.